Carcinoid Syndrome Impact Survey: Evaluation of the Burden of Illness and the Gap Between Patient and Oncologist Perceptions

November 2017 Vol 8, No 11
Kathleen Evans, MBA
Grace Goldstein, MA
Pablo Lapuerta, MD
Arpan Shah, PharmD, MBA

Background: Patients with advanced neuroendocrine tumors may develop carcinoid syndrome, a rare condition characterized by debilitating symptoms, including diarrhea, flushing, and valvular heart damage, that can greatly affect patient social and physical functioning. Limited information is available on the physician perceptions of carcinoid syndrome and areas that differ from patient perceptions.

Objectives: The Carcinoid Syndrome Impact Survey was designed to probe potential gaps in oncologist, patient, and caregiver perceptions and the overall burden of the disease.

Methods: The survey, designed in collaboration with patient advocacy groups, was conducted (June-October 2016) among 538 patients with carcinoid syndrome, 94 caregivers, and 151 oncologists. The online, anonymous survey consisted of demographic and disease-related questions, including symptom frequency and impact on daily living of carcinoid syndrome. Each group of respondents was given mirrored questions whenever possible to allow for comparison across groups. Questions were based primarily on a 4-level Likert scale.

Results: Differences in perception of symptom frequency, syndrome severity, and impact of carcinoid syndrome on daily living were observed between patients, caregivers, and oncologists. Patients and caregivers were more likely to report symptom frequency as >21 days per month (39% of caregivers vs 38% of patients vs 4% of oncologists). Most oncologists cited symptom frequency as 1 to 7 days per month (50% of oncologists). Patients were more likely to report carcinoid syndrome affecting them “a great deal” (62% of patients vs 23% of oncologists). Caregivers were most likely to report the highest category of severity compared with patients and physicians (39% of caregivers vs 25% of patients vs 17% of oncologists).

Conclusions: Oncologists may not be fully aware of the impact of carcinoid syndrome on patient daily living. Furthermore, caregivers may perceive aspects of disease burden to which patients have habituated and may not report as frequently. Tools to encourage more explicit dialogue between patients with carcinoid syndrome and oncologists are needed to narrow the information gap and subsequently improve treatment outcomes.

Funding: Lexicon Pharmaceuticals, Inc.

Previously Presented At: ASCO Quality Care Symposium, March 3-4, 2017.

Related Articles
Our Health History Is in the Stories We Tell Within Black and Brown Families
Maimah Karmo
|
May 2023 Vol 14, No 5

With National Black Family Cancer Awareness Week (June 15-21, 2023) on the horizon, it is paramount to acknowledge the pivotal role that nurse navigators play in educating and empowering patients and their loved ones—to include fostering candid and transparent conversations about family health history, knowing our bodies, risk reduction, and proactive cancer screenings. As a breast cancer survivor and founder of the Tigerlily Foundation, I am a testament to the profound, lifesaving impact of these conversations. My mother was a nurse, and I often say that she gave me life and saved my life. Here’s how.

Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country